Wellington Management Group’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$155M Sell
8,976,962
-3,326,290
-27% -$57.6M 0.03% 418
2025
Q1
$269M Buy
12,303,252
+502,403
+4% +$11M 0.05% 278
2024
Q4
$377M Sell
11,800,849
-3,766,120
-24% -$120M 0.07% 230
2024
Q3
$449M Sell
15,566,969
-821,728
-5% -$23.7M 0.08% 223
2024
Q2
$629M Buy
16,388,697
+1,330,626
+9% +$51M 0.11% 179
2024
Q1
$885M Sell
15,058,071
-1,387,219
-8% -$81.5M 0.16% 149
2023
Q4
$984M Buy
16,445,290
+1,278,246
+8% +$76.5M 0.18% 132
2023
Q3
$577M Buy
15,167,044
+8,502,769
+128% +$323M 0.12% 178
2023
Q2
$607M Sell
6,664,275
-1,614,164
-19% -$147M 0.12% 178
2023
Q1
$546M Sell
8,278,439
-479,222
-5% -$31.6M 0.11% 187
2022
Q4
$453M Sell
8,757,661
-1,199,755
-12% -$62M 0.09% 212
2022
Q3
$680M Sell
9,957,416
-1,585,327
-14% -$108M 0.14% 149
2022
Q2
$522M Sell
11,542,743
-2,656,551
-19% -$120M 0.11% 186
2022
Q1
$721M Buy
14,199,294
+1,868,641
+15% +$94.9M 0.12% 173
2021
Q4
$583M Buy
12,330,653
+1,159,081
+10% +$54.8M 0.09% 207
2021
Q3
$368M Buy
11,171,572
+457,747
+4% +$15.1M 0.06% 285
2021
Q2
$677M Buy
10,713,825
+225,721
+2% +$14.3M 0.11% 186
2021
Q1
$450M Sell
10,488,104
-20,007
-0.2% -$859K 0.08% 242
2020
Q4
$601M Buy
10,508,111
+55,303
+0.5% +$3.16M 0.11% 190
2020
Q3
$315M Buy
10,452,808
+8,297
+0.1% +$250K 0.07% 262
2020
Q2
$341M Buy
10,444,511
+72,513
+0.7% +$2.37M 0.08% 228
2020
Q1
$278M Buy
10,371,998
+6,054,734
+140% +$162M 0.07% 238
2019
Q4
$132M Buy
4,317,264
+685,390
+19% +$21M 0.03% 498
2019
Q3
$87.5M Sell
3,631,874
-1,513,433
-29% -$36.5M 0.02% 580
2019
Q2
$130M Buy
5,145,307
+1,268,333
+33% +$32.1M 0.03% 491
2019
Q1
$75.6M Buy
3,876,974
+3,861,326
+24,676% +$75.3M 0.02% 623
2018
Q4
$206K Buy
+15,648
New +$206K ﹤0.01% 2007